Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation

Clinical Transplantation

Volumn 13, Issue 6, 1999, Pages 447-452

  Rayes, N ^a   Seehofer, D ^a   Bechstein, W O ^a   Muller A R ^a   Berg, T ^a   Neuhaus, R ^b   Neuhaus, P ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Famciclovir; HBV; Liver transplantation

Indexed keywords

CYCLOSPORIN A; FAMCICLOVIR; HEPATITIS B ANTIBODY; PREDNISOLONE; TACROLIMUS; VIRUS DNA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SEROLOGY; SIDE EFFECT; VIRUS REPLICATION;

2-AMINOPURINE; ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS B; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; TIME FACTORS;

EID: 0033405628     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.130602.x     Document Type: Article

References (32)

1. TODO S, DEMETRIS AJ, VAN THIEL DH, TEPERMAN L, FUNG JJ, STARZL TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991: 13: 619.
2. VAN THIEL DH, WRIGHT HI, FAGIUOLI S. Liver transplantation for hepatitis B virus-associated cirrhosis: a progress report. Hepatology 1994: 20: 20S.
3. VILLAMIL FG, VIERLING JM. Recurrence of viral hepatitis after liver transplantation: insights into management. Liver Transplant Surg 1995: 1 (5, Suppl 1): 89.
4. DEMETRIS AJ, TODO S, VAN THIEL DH et al. Evolution of hepatitis B virus liver disease after hepatic replacement. Am J Pathol 1990: 137: 667.
5. CRIPPIN J, FOSTER B, CARLEN S, BORCICH A, BODENHEIMER H. Retransplantation in hepatitis B: a multicenter experience. Transplantation 1994: 57 (6): 823.
6. SAMUEL D, MULLER R, ALEXANDER G, FASSATI L, DUCOT B, BENHAMOU JP, BISMUTH H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993: 329: 1842.
7. MAIN J, BROWN JL, HOWELLS C, GALASSINI R, CROSSEY M, KARAYIANNIS P, GEORGIOU P, ATKINSON G, THOMAS HC. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepatitis 1996: 3: 211.
8. GHANY MG, AYOLA B, VILLAMIL FG, GISH RG, ROJTER S, VIERLING JM, LOK ASF. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998: 27: 213.
9. SAFADI R, EID A, ILAN Y, ASHUR Y, JURIM O, SHOUVAL D. Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation. Transplant Proc 1997: 29: 2680.
10. HOPF U, NEUHAUS P, LOBECK H, KÖNIG V, KÜTHER S, BAUCLITZ X, BECHSTEIN WO, BLUMHARDT G, STEFFEN R, NEUHAUS R, HUHN D. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon a. J Hepatol 1991: 13: 339.
11. KRÜGER M, TILLMANN HL, TRAUTWEIN C, BODE U, OLDHAFER K, MASCHEK H, BÖKER KHW, BROELSCH CE, PICHLMAYR R, MANNS MP. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transplant Surg 1996: 2 (4): 253.
12. BÖKER KHW, RINGE B, KRÜGER M, PICHELMAYR R, MANNS MP. Prostaglandin E plus famciclovir - a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994: 57: 1706.
13. HALLER GW, BECHSTEIN WO, NEUHAUS R, RAAKOW R, NEUHAUS P. Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation. Transpl Int 1996: 9: 210.
14. SCHALM SW, DE MAN RA, HEITJINK RA, NIESTERS HGM. New nucleoside analogues for chronic hepatitis B. J Hepatol 1995: 22: 52.
15. MASON AL, XU L, GUO L, KUHNS M, PERRILLO RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998: 27: 1736.
16. FONTANA RJ, LOK ASF. Combination therapy for chronic hepatitis B. Hepatology 1997: 26: 234.
17. SINGH N, GAYOWSKI T, WANNSTEDT CF, WAGENER MM, MARINO IR. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Transplantation 1997: 63: 1415.
18. AYE TT, BARTHOLOMEUSZ A, SHAW T, BOWDEN S, BRESCHLEIN A, MCMILLAN J, ANGUS P, LOCARNINI S. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 1997: 26 (5): 1148.
19. DIENSTAG JL, PERRILLO RP, SCHIEF ER, BARTHOLOMEW M, VICARY C, RUBIN M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995: 333: 1657.
20. NERY JR, WEPPLER D, RODRIGUEZ M, RUIZ P, SCHIFF ER, TZAKIS AG. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation 1998: 65: 1615.
21. CHAYAMA K, SUZUKI Y, KOBAYASHI M, KOBAYASHI M, TSUBOTA A, HASHIMOTO M, MIYANO Y, KOIKE H, KOBAYASHI M, KOIDA I, ARASE Y, SAITOH S, MURASHIMA Y, IKEDA K, KUMADA H. Emergence and take-over of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 1998: 27: 1711.
22. HONKOOP P, NIESTERS HGM, DE MAN RAM, OSTERHAUS ADME, SCHALM SW. Lamivudine resistance in immunocompetent chronic hepatitis B. J Hepatol 1997: 26: 1393.
23. GISH RG, LAU JYN, BROOKS L, FANG JWS, STEADY SL, IMPERIAL JC, GARCIA-KENNEDY R, ESQUIREL CO, KEEFE EB. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996: 23: 1.
24. DOUGLAS DD, RAKELA J, TASWELL HF, KROM RAF, WIESNER RH. Hepatitis B virus patterns after orthotopic liver transplantation: de novo versus recurrent infection. Transplant Proc 1993: 25 (2): 1755.
25. NEUHAUS P, STEFFEN R, BLUMHARDT G, BECHSTEIN WD, KECK H, LEMMENS HP, NEUHAUS R, LOBECK H, KÖNIG V, HOPF U. Experience with immunoprophylaxis and interferon therapy after liver transplantation in Hb-sAG positive patients. Transplant Proc 1991: 23 (1): 1522.
26. MULLER R, SAMUEL D, FASSATI LR, BENHAMOU JP, BISMUTH H, ALEXANDER GJM. EUROHEP consensus report on the management of liver transplantation for hepatitis B virus infection. J Hepatol 1994: 21: 1140.
27. TERRAULT NA, WRIGHT TL. Hepatitis B virus infection and liver transplantation. Gut 1997: 40: 568.
28. TERRAULT NA, HOLLAND CC, FERRELL L, HAHN JA, LAKE JR, ROBERTS JP, ASHER NL, WRIGHT TL. Interferon alpha for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 1996: 2: 132.
29. CHIEN RN, LIAW YF, CHEN TC, YEH CT, SHEEN LS. Efficacy of thymosin al in patients with chronic hepatitis B: a randomized, controlled trial. Hepatology 1998: 27: 1383.
30. GISH RG, KEEFE EB, LIM J, BROOKS LJ, ESQUIVEL CO. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. J Hepatol 1995: 22: 257.
31. TCHERVENKOV JI, TECTOR AJ, BARKUN JS, SHERKER A, FORBES CD, ELIAS N, CANTAROVICH M, CLELAND P, METRAHOS P, MEAKINS JL. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg 1997: 226 (3): 356.
32. COLLEDGE D, LOCARNINI S, SHAW T. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology 1997: 26: 216.